BioCeuticals Ubiquinol BioActive 300mg 30c

Description

Ubiquinol BioActive 300mg provides a high dose of ubiquinol per capsule. Ubiquinol is the reduced (active) form of coenzyme Q10 with superior absorption and higher bioavailability that other forms of CoQ10 such as ubiquinone/ubidecarenone.

Features:

• Provides 300mg ubiquinol per capsule.
• Ubiquinol displays superior absorption and increased bioavailability compared with other forms of CoQ10.
• Provides nutritional support for healthy cardiovascular function.
• May reduce the frequency of migraine headaches, when used prophylactically.
• Provides nutritional support for the maintenance of normal healthy sperm's motility and morphology.
• Supports healthy energy synthesis.
• May enhance physical power production.
• May help reduce the oxidation of LDL cholesterol as well as LDL cholesterol levels in healthy people.
• May benefit individuals experiencing increased oxidative stress as occurs in normal ageing.
• Beneficial for individuals with increased oxidative stress.
• Highly efficient and potent antioxidant that is involved in the regeneration of other antioxidants.

 

Each capsule contains:
Ubiquinol-10 (reduced coenzyme Q10)	300mg

 

No added dairy, gluten, shellfish, soy protein, yeast.

• If symptoms persist consult your healthcare practitioner.
• Vitamin supplements should not replace a balanced diet.
• Do not take while on warfarin therapy without medical advice.
• Always read the label. Use only as directed.
• If you have any pre-existing conditions, are on any medications, always talk to your health professional before use.
• Some products should be ceased at least two weeks before any elective surgery, please confirm with your health professional.

Prescribing Information:

• Although generally well tolerated, the use of ubiquinol in pregnancy and lactation has not been scientifically validated.
• Do not take while on warfarin therapy without medical advice. CoQ10 may affect international normalised ratio (INR).
• Due to the slow synthesis of CoQ10-dependent enzymes, a clinical response may not occur until 8 or more weeks of therapy.
• Statin drugs are known to adversely affect CoQ10 levels by inhibiting the enzyme HMG-CoA reductase required for the synthesis of cholesterol in the liver as well as for CoQ10 production.